genOway Chosen by Tufts University for Major Framework Contract
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
genOway reports an important framework agreement with the Tufts University (Boston, USA).
Following an international competition, the company has been selected for a framework contract for a two years renewable period.
Under the terms of the agreement, researchers at the Tufts University, whose prestigious areas of study cover oncology, cardiovascular disease and virology (especially AIDS), will benefit from the expertise gained by genOway in transgenic technologies and technological innovations developed by the company, such as inducible systems that secure and accelerate the development of sophisticated genetically modified mouse and rat models.
The financial terms of the agreement were not disclosed.
Following an international competition, the company has been selected for a framework contract for a two years renewable period.
Under the terms of the agreement, researchers at the Tufts University, whose prestigious areas of study cover oncology, cardiovascular disease and virology (especially AIDS), will benefit from the expertise gained by genOway in transgenic technologies and technological innovations developed by the company, such as inducible systems that secure and accelerate the development of sophisticated genetically modified mouse and rat models.
The financial terms of the agreement were not disclosed.
